Why Is Hims & Hers Stock Soaring After FDA’s Announcment?

All NewsApril 16, 2026

Hims & Hers stock rises as FDA plans to ease peptide therapy rules, opening new revenue opportunities and shifting regulatory outlook.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Why Is Hims & Hers Stock Soaring After FDA’s Announcment?

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

South Korea’s finance chief bets chip boom outlasts selloff

What has actually battered the bond market?

Bitget plans Thai crypto exchange acquisition weeks after $388M hack

Bath & Body Works faces surprising problem as Americans return to malls

JPMorgan projects Bitcoin to outperform US stocks and gold over next decade